Mark Webster

Research interests

Publications

• An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition)

  EuroIntervention · 2015 · https://doi.org/10.4244/eijy15m02_03

• A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation

  JACC: Cardiovascular Interventions · 2013 · https://doi.org/10.1016/j.jcin.2013.07.007

• Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease

  JACC: Cardiovascular Interventions · 2013 · https://doi.org/10.1016/j.jcin.2013.05.017

• Stent Longitudinal Integrity

  JACC: Cardiovascular Interventions · 2011 · https://doi.org/10.1016/j.jcin.2011.11.002

• Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

  EuroIntervention · 2010 · https://doi.org/10.4244/eij30v6i4a76

• A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

  The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)60325-1

• The Antiplatelet Effect of Six Non-Steroidal Anti-Inflammatory Drugs and Their Pharmacodynamic Interaction With Aspirin in Healthy Volunteers

  The American Journal of Cardiology · 2008 · https://doi.org/10.1016/j.amjcard.2007.11.054

• A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

  The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)60415-8

• The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response

  JACC: Cardiovascular Interventions · 2008 · https://doi.org/10.1016/j.jcin.2008.09.008

• First‐in‐human implantation of a fully bioabsorbable drug‐eluting stent: The BVS poly‐ L ‐lactic acid everolimus‐eluting coronary stent

  Catheterization and Cardiovascular Interventions · 2006 · https://doi.org/10.1002/ccd.20895

• Drug‐eluting stents for coronary bifurcations: Bench testing of provisional side‐branch strategies

  Catheterization and Cardiovascular Interventions · 2005 · https://doi.org/10.1002/ccd.20453

• Drug‐eluting stents for coronary bifurcations: Insights into the crush technique

  Catheterization and Cardiovascular Interventions · 2004 · https://doi.org/10.1002/ccd.20120

• Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients

  Circulation · 2004 · https://doi.org/10.1161/01.cir.0000116750.63158.94

• Stent deformation following simulated side-branch dilatation: A comparison of five stent designs

  Catheterization and Cardiovascular Interventions · 1999 · https://doi.org/10.1002/(sici)1522-726x(199906)47:2<258::aid-ccd27>3.0.co;2-c

• Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs.

  Circulation · 1993 · https://doi.org/10.1161/01.cir.88.6.2923

• Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.

  Circulation · 1990 · https://doi.org/10.1161/01.cir.82.4.1476

• PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS

  The Lancet · 1988 · https://doi.org/10.1016/s0140-6736(88)92944-3

• Effect of enalapril on ventricular arrhythmias in congestive heart failure

  The American Journal of Cardiology · 1985 · https://doi.org/10.1016/0002-9149(85)91186-5

• RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERS

  The Lancet · 1985 · https://doi.org/10.1016/s0140-6736(85)91207-3

Current projects

No projects listed.